Thryve Review: Price, Pros & Cons
A single-page signup advertising '$99/mo GLP-1' without naming a drug, a dose, a state or a single clinician.
In this review
Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.
Prices at a glance
- Semaglutide
- $99/moDrug not specified — site never names semaglutide or tirzepatide
- Tirzepatide
- $99/moDrug not specified — site never names semaglutide or tirzepatide
- Coverage
- Not disclosed
- Brand-name
- Not confirmed
Semaglutide · estimated annual cost
$1,188
Tirzepatide · estimated annual cost
$1,188
Who Thryve may suit
Shoppers willing to ask which drug, dose and states the $99/mo GLP-1 offer covers before paying, since the site doesn't say.
Where the value is
- A low headline price is advertised, if a reader wants to investigate directly
The tradeoffs
- Never names which drug is being sold — no mention of semaglutide, tirzepatide, or any other active ingredient anywhere on the site
- No dose, no state-coverage list, no named clinician, and no named pharmacy
- The only contact details on the site are template placeholders: a phone number of '+123 12345 67890' and the address 'demo@gmail.com'
- Its FAQ, program details, terms and privacy policy pages are missing, so you can't read the terms before you buy
- The site's own footer disclaimer states 'GLP-1 is a peptide currently under clinical research' — factually inaccurate, since semaglutide and tirzepatide are FDA-approved medications, not investigational
- No LegitScript badge or any other third-party verification
What Thryve advertises
Thryve is a one-page website advertising a "GLP-1" weight-loss program "starting at $99/month," with a money-back weight-loss guarantee. You book a consultation to find out whether you're eligible.
That's nearly all it says. It never names the medication. Semaglutide and tirzepatide aren't mentioned anywhere. Instead, it describes a "next-generation peptide" that it says works on several metabolic pathways, including by mimicking glucagon. It also calls GLP-1 "a peptide currently under clinical research" and says it's being studied in advanced clinical trials.
Considering Thryve?
Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.
Why that matters
Semaglutide and tirzepatide are approved, prescription medications. A drug described as still under clinical research is a different thing, and a seller that won't say what's in the vial is asking you to take a lot on trust. Before you pay anything, ask Thryve in writing which drug it prescribes, at what dose, from which pharmacy, and under which licensed clinician.
Missing basics
Thryve's contact details are template placeholders, a phone number of "+123 12345 67890" and a sample email address from a website template. Its FAQ, program details, terms and privacy policy aren't available, so there are no published rules on billing, canceling, refunds or the guarantee. It doesn't list the states it serves or name a doctor or pharmacy. Without terms, you also can't check what the guarantee requires, how long a plan runs, or whether the $99 is a first-month price.
If you do contact Thryve, don't send payment details until you have those answers in writing. A legitimate prescriber will tell you the drug name, the dose and the pharmacy before you're charged.
If you want GLP-1 treatment from a company that names its medication and its terms, compare compounded semaglutide providers or compounded tirzepatide providers.
The Index scorecard
Thryve scored on our six Cost-Efficiency Index factors. See the methodology.
The bottom line
A single-page signup advertising '$99/mo GLP-1' without naming a drug, a dose, a state or a single clinician.
Compare the total cost of other GLP-1 programs and alternatives to Thryve before deciding. A clinician should help you choose the right treatment.
Other programs to compare with Thryve
These are partners: we may earn a commission if you sign up, at no cost to you.
WellorithmPartner
brand-name Semaglutide modeled $899/mo · brand-name Tirzepatide modeled $1,199/mo
Wellorithm sells brand Wegovy at $899 a month and Zepbound or Ozempic at $1,199, with compounded semaglutide and dissolving tablets offered but not priced until you start the quiz.
Gala HealthPartner
Tirzepatide modeled $179/mo
Every dose at one published price, with the whole price list visible before you hand over an email — but the only terms it sells on are a yearly subscription at $179 or a three-month plan at $199, so there is no monthly number here to compare with anyone else's.
Direct MedsPartner
Semaglutide modeled $249/mo · Tirzepatide modeled $299/mo
Direct Meds sells semaglutide and tirzepatide both as a sublingual and as an injection, every product priced in the open, from $249 a month on a plan that bills against a 90-day supply.
Compare with other providers
The providers whose Cost-Efficiency Index scores sit closest to Thryve's. See the alternatives to Thryve.
- Align Pharmacy— Align Pharmacy is a Louisiana compounding pharmacy that supplies physicians and clinics in 29 states; it has no patient ordering and names no GLP-1 product.36/100
- Midtown Express Pharmacy— Midtown Express Pharmacy is a Nashville neighborhood pharmacy with refills, delivery and non-sterile compounding; it doesn't prescribe or offer a GLP-1 program.36/100
- Shields Pharmacy— Shields Pharmacy is a Florida compounding pharmacy that works with more than 5,000 providers and ships to their patients; you can't order from it without a prescriber.36/100
Explore more provider reviews
Pricing, states and verification reflect Thryve's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Thryve's site. Not medical advice; see our disclosure.